பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

CISF to provide round-the-clock security at Covaxin manufacturer Bharat Biotech's Hyderabad campus

COVID-19: Bharat Biotech Submits New Request To Brazilian Regulator On Good Manufacturing Practices For Covaxin


Bharat Biotech has signed an agreement with Brazil for supply of 20 million doses of Covaxin.
Hyderabad:
Bharat Biotech which faced a red flag from Brazil s health regulator for supply of COVID-19 vaccine Covaxin to that country over the issues of Good Manufacturing Practices in its plant, has filed a new request to the Brazilian authorities for certification.
According to the National Health Surveillance Agency of Brazil Anvisa, Bharat Biotech made the request on May 25 and a day before the Ministry of Health of the South American country filed a new application for authorisation to import 20 million doses of the Covaxin. ....

United States , Rio De Janeiro , Estado Do Rio , Mato Grosso , National Health Surveillance Agency Of Brazil Anvisa , Bharat Biotech International Limited On , Ministry Of Health The South American , Bharat Biotech , Good Manufacturing Practices , National Health Surveillance Agency , Brazil Anvisa , South American , Good Manufacturing Practice , Biotech International Limited , Good Production Practices , Precis Farmacutica , ஒன்றுபட்டது மாநிலங்களில் , ரியோ டி ஜானிரோ , எஸ்டாடோ செய் ரியோ , மாதோ மொத்த , பாரத் பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை ஆன் , பாரத் பயோடெக் , நல்ல உற்பத்தி ப்ர்யாக்டிஸஸ் , தெற்கு அமெரிக்கன் , நல்ல உற்பத்தி ப்ர்யாக்டீஸ் , பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை ,

Startup news and updates: daily roundup (May 25, 2021)


WhatsApp on Monday said it would not limit the functionality for users not agreeing to its new privacy policy but will continue to remind users about the update, and maintain this approach till the forthcoming data protection law comes into effect.
Days after the government directed the messaging platform to withdraw its new privacy policy, a WhatsApp spokesperson said the company had responded to the letter and has assured that the privacy of users remains the highest priority for the Facebook-owned entity.
Bharat Biotech International Limited (BBIL) has conveyed to the government that it has submitted 90 percent of the documentation to the WHO for obtaining an emergency use listing for the Covaxin vaccine and the remaining details will be supplied next month, sources said on Monday. ....

Raghunath Subramanian , Department Of Telecom Do , Bharat Biotech International , Us International Development Finance Corporation , Cellular Operator Association Of India , Worldbusiness Capital Inc Funding , Simple Energy , Worldbusiness Capital Inc , Biotech International Limited , Bharat Biotech Twitter , Pratap Chandra Sarangi , Manappuram Finance , Development Finance Corporation , Asirvad Microfinance , Cellular Operator Association , ரகுநாத் சுப்ரமணியன் , துறை ஆஃப் தொலை தொடர்பு செய் , பாரத் பயோடெக் சர்வதேச , எங்களுக்கு சர்வதேச வளர்ச்சி நிதி நிறுவனம் , செல்லுலார் ஆபரேட்டர் சங்கம் ஆஃப் இந்தியா , எளிய ஆற்றல் , பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை , பிரதாப் சந்திரா சாரங்கி , மனப்பூறம் நிதி , வளர்ச்சி நிதி நிறுவனம் , ஆசிர்வத் நுண்நிதி ,

Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine


Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine
Firstpost
5 days ago
© Provided by Firstpost
Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine
Bharat Biotech International Limited (BBIL) has applied to the World Health Organisation (WHO) to get an emergency use listing (EUL) for its COVID-19 vaccine. It hopes to get the nod by the third or fourth quarter of this year. BBIL has submitted 90 percent of required documents to WHO to get approval, and the remaining documents will be submitted by June, the Hyderabad-based pharma company told the Central government during a discussion. The meeting was attended by the company s managing director V Krishna Mohan and his colleagues, along with senior officers of the Ministry of Health, Department of Biotechnology and Ministry of External Affairs and Foreign Secretary Harsh Vardhan Shringla. Speaking to  ....

United Kingdom , India General , Andhra Pradesh , Astrazeneca Oxford , V Krishna Mohan , Raches Ella , Janssen Johnson , Vardhan Shringla , European Union , Bharat Biotech International Limited , Drug Administration , Ministry Of Health , Department Of Biotechnology , World Health Organisation , Ministry Of External Affairs , Bharat Biotech , Firstpost Bharat Biotech , Biotech International Limited , External Affairs , Foreign Secretary Harsh Vardhan , Hindustan Times , ஒன்றுபட்டது கிஂக்டம் , இந்தியா ஜநரல் , ஆந்திரா பிரதேஷ் , வ் கிருஷ்ணா மோகன் , ஜான்சன் ஜான்சன் ,